Earnings Feed
Start Free
U.S. Stem Cell, Inc.·4

Sep 1, 4:01 PM ET

TOMAS MIKE 4

4 · U.S. Stem Cell, Inc. · Filed Sep 1, 2017

Insider Transaction Report

Form 4
Period: 2017-08-07
U.S. Stem Cell, Inc.USRM
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-07+15,000,000→ 36,841,284 total
    Exercise: $0.03Exp: 2027-08-07→ Common Stock (15,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-08-07+1,500,000→ 38,341,284 total
    Exercise: $0.03From: 2017-08-07Exp: 2017-08-07→ Common Stock (1,500,000 underlying)
Holdings

  • Common Stock

    9,793
Footnotes (1)
  • [F1]3,750,000 vest on 08/07/2018, 3,750,000 vest on 08/07/2019, 3,750,000 vest on 08/07/2020, and 3,750,000 vest on 08/07/2021.

Documents

1 file
  • 4
    form4-tomas082317.xmlPrimary

    OWNERSHIP DOCUMENT